Abstract
Background
Accumulating evidence suggests that hypoxic areas in the bone marrow are crucial for maintenance of hematopoietic stem cells (HSCs) by supporting a quiescent state of cell cycle and regulating the transplantation capacity of long-term (LT)-HSCs. In addition, HSCs seem to express a metabolic profile of energy production away from mitochondrial oxidative phosphorylation in favor of glycolysis. At oxygen deprivation, hypoxia inducible factor 1α (HIF-1α) is known to induce glycolytic enzymes as well as suppressing mitochondrial energy production by inducing pyruvate dehydrogenase kinase 1 (Pdk1) in most cell types. It has not been established whether PDK1 is essential for HSC function and mediates hypoxia-adapting functions in HSCs. While the Pdk gene family contains four members (Pdk1-4), it was recently shown that Pdk2 and Pdk4 have an important role in regulating LT-HSCs.
Principle findings
Here we demonstrate that PDK1 activity is crucial for transplantable HSC function. Whereas Pdkl, Pdk2, and Pdk3 transcripts were expressed at higher levels in different subtypes of HSCs compared to differentiated cells, we could not detect any major differences in expression between LT-HSCs and more short-term HSCs and multipotent progenitors. When studying HIF-1α-mediated regulation of Pdk activity in vitro, Pdk1 was the most robust target regulated by hypoxia, whereas Pdk2, Pdk3, and Pdk4 were not affected. Contrary, genetic ablation in a cre-inducible Hif-1α knockout mouse did not support a link between HIF-1α and Pdk1. Silencing of Pdk1 by shRNA lentiviral gene transfer partially impaired progenitor colony formation in vitro and had a strong negative effect on both long-term and short-term engraftment in mice.
Conclusions
Our study demonstrates that PDK1 has broad effects in hematopoiesis and is a critical factor for engraftment of both HSCs and multipotent progenitors upon transplantation to recipient mice. While Pdk1 was a robust hypoxia-inducible gene mediated by HIF-1α in vitro, we could not find evidence of any in vivo links between Pdk1 and HIF-1α.
Introduction
Hematopoietic stem cells (HSCs) are located in the bone marrow (BM) where the balance between self-renewal and differentiation is under the influence of both cell-intrinsic and extrinsic signals. Numerous factors have been identified during the last decades that regulate HSCs including secreted factors and supportive cells such as endosteal, perivascular, endothelial, mesenchymal, and stromal cells [1, 2]. In addition, the BM is considered a relatively hypoxic tissue where HSCs reside mainly within niches of limited oxygen availability [3–5]. Cellular adaptation to hypoxia involves several important steps that regulate glucose metabolism, which serves to inhibit respiration and favoring energy production via glycolysis, thereby avoiding excessive mitochondrial oxidative phosphorylation (OXPHOS) [6] that otherwise would induce cycling and exhaustion of HSCs [7]. Multiple evidences suggest that HSCs are located to hypoxic BM regions. Therefore, it has been hypothesized that HSCs are dependent on such an environment of low O2. As a consequence HSCs would utilize anaerobic metabolism for proper regulation and maintenance [6, 8].
In many cell types, a low metabolic profile is primarily mediated by hypoxia-inducible factors (HIFs). HIFs are heterodimeric transcription factors consisting of two subunits; constitutively expressed HIF-1β [9] and either oxygen-sensitive HIF-1α or HIF-2α, which are degraded at the protein level when exposed to oxygen [10] but is stabilized at low levels of oxygen [9, 11, 12]. An important role of HIF-1α in hematopoiesis and HSC quiescence was first demonstrated in conditional Hif-1α-/- mice, in which numbers of HSCs decreased when exposed to stress, such as aging or BM transplantation [13]. However, more recent studies suggest that HIFs are not indispensable for HSCs during steady-state in vivo. Thus, in different conditional knockout mice lacking either Hif-1α, Hif-2α, or both, or alternatively lacking Hif-1β impairing both HIF-1α and HIF-2α function, no clear evidence was provided for any short-term or long-term effects on the HSC compartment [14, 15]. Although these differences may be due to distinct mouse strains, HIFs may promote multiple functions in the BM and may be nonessential for proper HSC activity.
Repression of mitochondria function and oxygen consumption is regulated by HIF-1α-dependent activation of pyruvate dehydrogenase kinase 1 (Pdk1) [16, 17] or Pdk3 [18], two members of the Pdk family [19, 20]. It was recently reported that all four Pdk family gene members are expressed in HSCs. Furthermore, Pdk2 and Pdk4 seem to be targets of HIF-1α as genetically modified mice lacking the Hif-1α gene have been shown to display reduced levels of both Pdk2 and Pdk4 [21]. In contrast, it has not been established whether PDK1 mediates hypoxia-adapting functions via induction by HIF-1α in HSCs. In the present study, we show that hypoxic exposure of Lineage-Sca1+c-kit+ (LSK cells) favors a switch away from mitochondrial OXPHOS to glycolysis by induction of genes encoding glycolytic enzymes and Pdk1. We demonstrate an important role of PDK1 in transplantable HSCs where gene silencing of Pdk1 impaired the engraftment potential of both long-term (LT)-HSCs and multipotent progenitors (MPPs) upon transplantation to recipient mice. Compared with other Pdk gene family members, Pdk1 was the main target of Hif-1α when determined in vitro. Contrary, we could not find any evidence for HIF-1α-dependent regulation of Pdk1 in conditional Hif-1α-/- mice.
Materials and methods
Animal ethics and housing
This study was reviewed and approved by the Linköping Animal Ethical Committee. Mice were bred and housed 4 per cage under conventional conditions in microisolator filter-top cages in the fully-accredited animal facility at Linköping University. Animal rooms were provided with 10–12 air changes per 24 hour, and maintained at 22 (± 2°C and a relative humidity of 50 (±20) %. Animals remained on regular 12-hour light-dark cycling, and received ad libitum food and acidified water.
For bone marrow transplantation, mice were acclimated 1–2 weeks before exposure to ionizing radiation (9 Gy) and subsequent injection of donor cells (maximum volume of 0.2 ml). After transplantation, mice were observed daily for 14-day post-irradiation and maintained under sterile conditions in microisolater filter-top cages and provided with autoclaved food and water containing 111mg/L ciprofloxacin (Ciproxin: Uppsala, Sweden). From day 15, mice were routinely monitored at least three times per week by trained animal technicians. An in-house scoring system was used to follow all irradiated mice and at first sign of illness (general appearance, reduced movement, ruffled fur, weight loss) animals were euthanized by CO2 inhalation followed by cervical dislocation. The transplantations included 76 mice of which 7 died due to effects of the lethal radiation dose of 9 Gy, 5 without euthanasia. Thus, the results in this study are based on 69 successfully transplanted mice.
Mouse breeding and genotyping
Hif-1αflox/flox (B6.129-Hif1atm3Rsjo/J; Jackson Laboratory) mice [22] were mated to inducible Mx1-Cre mice to generate Mx1-Cre:Hif-1αflox/flox mice. Offspring were genotyped by PCR-based assay with DNA from mouse ear snips (primers used are listed in S1 Table). To generate Hif-1αΔ/Δ mice, the Cre transgene was induced by intraperitoneal injection of 400 μg poly I:poly C (pIpC; Sigma Aldrich, St Louis, MO) three times every 48 hours, into 7–12 week old mice. As a control, age-matched pIpC-treated Hif-1α+/+ mice were used.
Isolation and culture of bone marrow cells
Femurs, tibiae, and iliac crests were dissected from sacrificed 8–12 weeks old mice and crushed in PBS supplemented with 5% heat-inactivated FBS (HyClone UK Ltd, Cramlington, UK) using a mortar and pestle. Bone fragments were removed from marrow by filtering through 70 Δm nylon mesh (Thermo Fisher Scientific, Asheville, NC). BM cells were enriched by positive selection for c-kit (CD117) expressing cells using immunomagnetic beads (Miltenyi Biotec, Bergisch Gladbach, Germany) before cell sorting. LSK cells were grown in StemSpan serum-free medium (Stem Cell Technologies, Vancouver, BC) with 50ng/mL of murine stem cell factor (SCF), human thrombopoietin (TPO), and human IL-6 (PeproTech Inc., Rocky Hill, NJ). LT-HSCs were grown in StemSpan Serum-free medium with 50ng/mL of murine SCF and human TPO, and MPPs with 50ng/mL murine SCF, human TPO and human FLT3. Before methylcellulose cultures, MPPs were grown in StemSpan serum-free medium with 50ng/mL murine SCF, human TPO, human IL-6 and human FLT3. Standard conditions for normoxia (20% O2) were 37°C in 5% CO2, whereas hypoxia (1% O2) was reached by incubation in a CO2/O2 incubator (Innova CO-14 incubator, New Brunswick Scientific CO, Edison, NJ).
Flow cytometry and antibodies
To isolate LT-HSCs, ST-HSCs, MPPs, and LSK cells, mononuclear cells from BM were incubated with CD16/CD32 (Fc)-block (2.4G2, BD Biosciences, San Jose, CA). For isolation of LSK cells, APC- (BD Biosciences) or FITC-conjugated CD117 (2B8) and FITC- or Pacific Blue™-conjugated Sca-1 (D7) antibodies were added. For isolation of LT-HSC (CD34-FLT3-), ST-HSC (CD34+FLT3-), and MPP (CD34+FLT3+) cells, FLT3-Biotin (A2F10, eBioscience, San Diego, CA), streptavidin-Pe-Cy7 (eBioscience) and CD34-PE (MEC14.7) antibodies were added. Pe-Cy5-conjugated antibodies were used against lineage markers Gr-1 (RB6-8C5), Mac-1 (M1/70), B220 (RA-3-6B2), CD3 (145-2c11) and Ter-119. All antibodies were purchased from BioLegend (San Diego, CA) unless stated otherwise. Dead cells were detected with propidium iodide (1μg/mL, Molecular Probes, Eugene, OR) or 7-AAD (0.5μg/mL, Sigma Aldrich). Labeled cells were analyzed on FACSCanto™ II, or sorted on a FACSAria™ (both BD Biosciences). Re-analysis of sorted cells showed purity above 96%.
Methylcellulose colonies
MethoCult® methylcellulose medium with recombinant cytokines (StemCell Technologies) were diluted 1:10 with IMDM (PAA Laboratories) supplemented with 2% heat-inactivated FBS. 1 x 104 unfractionated BM cells from pIpC–treated Hif-1αΔ/Δ or Hif-1α+/+ mice were cultured in duplicate 35 mm dishes in normoxia. Colonies, mostly CFU-GM, were picked and cultured in IMDM supplemented with 20% heat-inactivated FBS, 50ng/mL SCF, and 25ng/mL murine IL-3 (both from Peprotech) for 48 hours at normoxia or hypoxia, after which the cells were lysed for PCR to evaluate successful gene ablation and qRT-PCR for gene expression analysis. For MPP colony formation, 500–1,000 GFP+ MPPs transduced with either one of two different Pdk1 shRNA lentivirus, or scramble control, were sorted into MethoCult® methylcellulose medium with IMDM, 2% FBS, GM-CSF (5 ng/ml), IL-3 (10 ng/ml), SCF (50 ng/ml), and TPO (50 ng/ml) (all from Peprotech) and allowed to form colonies for 8 days.
Lactate and ATP assays
Assays were performed using Lactate Assay kit and ATP bioluminescent assay kit (both from Sigma Aldrich) as recommended by the manufacturer. For lactate assays, approximately 5 x 104 cells were harvested and homogenized in 4 volumes of the supplied lactate assay buffer before addition of supplied master reaction mix and measurement of absorption at 579 nm with a VERSAmax tunable microplate reader (Molecular Devices, Sunnyvale, CA). The lactate production was calculated from a standard curve. For ATP assays, 500 freshly isolated or cultured LSK cells were assayed for intracellular ATP level in a chemoluminometer (BioOrbit, Turku, Finland) with an appropriate ATP standard.
Quantitative real-time PCR
Total RNA was isolated from LSK cells using RNeasy® micro kit (Qiagen), DNase treatment included. For LT-HSCs, ST-HSCs, MPPs, c-kit+, or c-kit-, 6.500 to 20.000 cells were directly sorted into the buffer RLT contained in the RNeasy® micro kit, and total RNA was extracted. cDNA was generated by annealing total RNA to random primers (60 min at 50°C and 15 min at 70°C) in reaction mixture containing 240 ng of random primer, 0.5 mM dNTP (Fermentas, Lithuania), 1x first strand buffer, 5 μM DTT, 2 units/μL RNaseOUT (Fermentas) and 5 units/μL SuperscriptIII reverse transcriptase (all reagents from Invitrogen unless stated otherwise). To quantify transcripts reactions were performed in 10 μL with 2x SYBR green master mix (Roche), 0.5 μM of forward and reverse primers, and 4–12 ng template, or FastStart Universal Probe Master (Rox) (Roche), 20x Assays-on-Demand™ probes (Applied Biosystems), RNase-free H2O and template equivalent to 370–2300 cells (freshly sorted) or 4-12ng template (cultured cells). Primers used are listed in S2 Table and probes in S3 Table. β-actin and Hprt were used for sample normalization. All samples were set in triplicates, non-template controls were used for all samples. qRT-PCR was initiated by holding for 10 min at 95°C and 40 cycles of 15s at 95°C and 60s at 60°C, and performed using 7900 HT Fast Real-time PCR System (Applied Biosystems). Relative expression was calculated by normalization to the reference gene.
Lentiviral and retroviral vectors
Complementary DNA short hairpin (sh) RNA MISSION™ interference lentiviral vectors targeting Pdk1 as well as non-targeting shRNA scramble control were designed by the RNAi Consortium (TRC) at the Broad institute and purchased from Sigma (listed in S4 Table). The shRNAs were subcloned to the lentiviral vector pLKO.1-EGFP (kindly provided by Dr. J. Larsson, Lund). cDNA encoding murine Hif-1α carrying two point mutations rendering the protein insensitive to oxygen dependent degradation (caHif-1α; double mutant P402A/P563A) was cloned in the retroviral vector pMy-EGFP (kindly provided by Jörg Cammenga, Linköping). Virus supernatants were obtained by calcium phosphate transfection of 293T cells together with the helper plasmids pMD.G and pCMVΔR8.2 (lentivirus) or pVSV-G and pGAG-pol (retrovirus) as previously described [23]. Cells were transduced using Retronectin™ (Takara, Tokyo) and spinfection at 1,800g in the presence of 5 μg Polybrene/mL (Sigma Aldrich). GFP+ cells were sorted on a FACSAria™ (BD Biosciences).
In vivo reconstitution
B6.SJL (CD45.1) and C57BL/6J (CD45.2) mice were used as donors and recipients, respectively. LT-HSCs, MPPs or LSK cells from CD45.1 mice were transduced with either one of two different Pdk1 shRNA lentivirus, or scramble control. After 2 days, the percent GFP+ cells were assessed by flow cytometry and 7 x 104 GFP+ LSK cells or MPPs, or 4.3 x 103 GFP+ LT-HSCs, were injected in the lateral tail vein of lethally irradiated (9 Gy) CD45.2 mice along with 2 x 105 BM supporter cells. Peripheral blood was collected by lateral tail vein bleeding of transplanted mice and stained with anti-CD45.1-Brilliant Violet 421 (A20), anti-CD45.2-PE/Cy7 (104–2), CD19-APC, B220-PE, Gr-1-APC-Cy7 and Mac-1-APC-Cy7 after red blood cell lysis using ammonium chloride. All antibodies were purchased from BioLegend. Dead cells were detected with 7-AAD (0.5μg/mL).
Statistical analysis
Data are expressed as the mean + standard deviation (SD), median ± interquartile range, or median and ranges. Statistical analysis was performed using Student`s t-test and Mann-Whitney U-test by GraphPad Prism 7 (GraphPad Software Inc., La Jolla CA).
Results
Hypoxia upregulates PDK1 and converts energy metabolism of LSK mouse bone marrow cells from mitochondrial oxidative phosphorylation to glycolysis
Measurements of the oxygen levels in the BM of living mice has displayed oxygen tension to be rather low and in the range of 10–30 mmHg in HSC niches [5]. This corresponds to an oxygen level of approximately 1–1.5% O2 and has been used by others and us in previous studies [23–26]. We first wanted to confirm that hypoxic exposure led to upregulation of genes associated to glycolytic activity (depicted schematic in Fig 1A). Twenty-four hours of incubation at 1% O2 of LSK cells led to a clear increase of lactate production (Fig 1B) and a slight increase of intracellular ATP production (Fig 1C). The RNA expression of glucose transporter Glut1, lactate dehydrogenase A (Ldha) and phosphoglycerate kinase 1 (Pgk1) increased, and a trend of higher expression of hexokinase 2 (Hk2) was observed (Fig 1D). Pdk1 was also upregulated; however, hypoxia did not have any major effect on Pdk2 and Pdk3 (Fig 1E), and Pdk4 expression was below the detection limit (S1 Fig).
It has previously been suggested that Pdk2 and Pdk4 expression is higher in more primitive progenitor cells [21]. We therefore analyzed whether Pdk1 is distinctly expressed in various BM cell populations. We performed qPCR expression analysis of the Pdk gene family in LT-HSCs, ST-HSCs, and MPPs that are all included within LSK cells. It has been demonstrated that these progenitor populations form a sequential developmental lineage where LT-HSCs give rise to ST-HSCs followed by MPPs [27–29]. LT-HSCs have life-long self-renewal ability and contribute to long-term multi-lineage reconstitution of irradiated hosts upon transplantation. In contrast, ST-HSCs have limited self-renewal ability and can only support reconstitution of the hematopoietic system for about 6 weeks. MPPs can support the generation of all mature blood cells types but maintain no obvious self-renewal capacity, and as a consequence they can only support hematopoiesis transiently [28–30].
Fig 2A shows the gating strategy by FACS for isolating the three cell populations from the BM. We also included progenitor cells expressing or lacking c-kit expression as two examples of more differentiated progeny where c-kit- cells are the most differentiated. Expression analysis demonstrated that LT-HSCs, ST-HSCs, and MPPs expressed higher levels of Pdk1 compared to more differentiated c-kit+ and c-kit- cells (Fig 2B). In addition, expression of Pdk2 and Pdk3 was higher in LT-HSCs compared to differentiated cells (Fig 2B), whereas Pdk4 was not detected (not shown).
Pdk1 expression is upregulated by HIF-1α during hypoxic culture of LSK cells in vitro, but Pdk1 is not an HIF-1α target in vivo
To investigate if the upregulation of Pdk1 in hypoxia was mediated by HIF-1α, LSK cells were transduced with constitutively active and oxygen-insensitive Hif-1α (caHif-1α), previously shown by us to be stable at the protein level in ambient air [23]. In normoxia, overexpression of caHif-1α led to increased Pdk1 expression but not of Pdk2 or Pdk3 (Fig 3A). To define the in vivo role of HIF-1α for Pdk1 expression, we deleted Hif-1α specifically in hematopoietic cells using Mx1-Cre:Hif1αflox/flox (Hif-1αΔ/Δ) mice by multiple pIpC-injections. Four weeks after treatment, the effect of HIF-1α deficiency was assessed by quantitative real-time (qRT-PCR) analysis in sorted BM populations (experimental design in Fig 3B). The efficiency of Hif-1α ablation was assessed by PCR analysis of genomic DNA in total BM, showing nearly complete knockout (S2A Fig). Although there was a trend towards decreased expression of Pdk1 in LT-HSCs from Hif-1αΔ/Δ mice compared to ST-HSCs, MPPs, c-kit+ and c-kit- cells, the difference was not significant (Fig 3C).
To directly measure the effects of hypoxia on progenitors lacking HIF-1α, we decided to determine the expression of Pdk1 in BM progenitors isolated from Hif-1αΔ/Δ mice upon exposure to hypoxia in vitro. The analysis was performed by seeding BM cells from either Hif-1α+/+ or Hif-1αΔ/Δ mice in semi-solid methylcellulose, and allowing colonies to form in normoxia for 9–12 days. Then multiple individual colonies (mainly colony forming unit-granulocyte/macrophage; CFU-GM) were isolated and examined for deletion of Hif-1α by PCR analysis (S2B Fig). The remaining cells from each colony were grown in suspension for an additional 48 hours in normoxia or hypoxia, after which RNA was isolated and expression of Pdk1-4 was determined. In hypoxia, expression of Pdk1 was reduced 22-fold and almost completely abolished in colonies of Hif-1αΔ/Δ mice (Fig 3D). There was also a decrease in Pdk3 expression whereas Pdk2 was unaffected. This observation is consistent with a role of HIF-1α in regulating Pdk1 expression. However, in normoxia deletion of Hif-1α also led to decreased expression of Pdk1, although at a lower level (3.8-fold). These findings suggest that Pdk1 is a target for HIF-1α, but that HIF-1α can regulate Pdk1 even in a non-hypoxic environment. Since no effects of Pdk1 expression was seen in BM cells of Hif-1αΔ/Δ mice, the results raise questions to whether HIF-1α regulates Pdk1 differently during in vitro and in vivo conditions.
PDK1 is important for long-term hematopoietic engraftment
Despite any clear evidence for HIF-1α-mediated regulation of Pdk1 in vivo utilizing Hif-1α Δ/Δ mice, we decided to assess the importance of PDK1 in transplantation assays to compare the ability of LSK cells with no PDK1 expression to reconstitute the hematopoietic system in irradiated host mice. This was done with LSK cells with silenced Pdk1 expression using two different shRNA lentiviruses, both efficiently reducing the RNA level of Pdk1 in both normoxia and hypoxia (S3 Fig). A non-targeting scramble shRNA was used as control. Forty-eight hour post-transduction, 7 x 104 GFP+ LSK cells from CD45.1 mice were transplanted to CD45.2 mice along with BM supporter cells. Peripheral blood was analyzed for GFP expression after 4, 8, and 16 weeks (experiment depicted in Fig 4A). At all time, engraftment was significant lower in recipients transplanted with any of the two shRNAs to Pdk1 compared to controls (Fig 4B). When the effects on myeloid and lymphoid contribution of transplanted cells were analyzed, no difference was seen between cells with control or Pdk1 shRNA and both groups showed a clear bias towards lymphoid reconstitution (Fig 4C). This is in agreement with published results that engrafting LSK cells give mainly rise to lymphocytes in irradiated mice due to selective expansion of lymphoid progenitors [29, 31]. Taken together, the results demonstrate an important role of PDK1 during engraftment of HSCs to the BM of recipient mice but no distinct effect on any certain hematopoietic cell lineage.
Pdk1 silencing impairs MPP function both in vitro and in vivo
Since our results implied that PDK1 was essential for HSC engraftment, and Pdk1 expression was higher in both LT-HSCs and MPPs compared to later progeny, we decided to determine the effects of Pdk1 silencing of MPPs in vitro and in vivo. We first tested if Pdk1 silencing affected the clonality of MPPs by plating them (500–1,000 cells per plate) after cell sorting in semi-solid methylcellulose media supplemented with cytokines (GM-CSF, IL-3, SCF, and TPO). To determine if any effects were linked to hypoxia, MPPs were incubated in parallel plates either in hypoxia and normoxia. After 8 days the numbers of colonies were scored. Overall the plating efficiency was slightly higher in hypoxia. MPPs infected with either of the two Pdk1 shRNAs displayed lower clonogenic potential in both conditions and the numbers of colonies decreased by approximately 25% (Fig 5A). This in vitro experiment indicates that although MPPs retain clonogenicity in the absence of PDK1, the ability is partially lost even in normoxia, and is thus not entirely dependent on hypoxia.
We then addressed whether PDK1 is important for short-term engraftment by transplantation of MPPs to recipient mice. To compare the effects of MPPs to another transplantable cell population, the time kinetics for engraftment of MPPs at 3 and 6 weeks were compared to LT-HSCs in parallel. The two cell populations were FACS-sorted and transplanted separately to recipient mice after Pdk1 gene silencing. After 3 and 6 weeks, the percent GFP+ cells in peripheral blood was determined in mice (experiment depicted in Fig 5B) receiving either MPPs (Fig 5C) or LT-HCSs (Fig 5D). In both cases, there was a reduction in the engraftment potential of MPPs and LT-HSCs when expressing shRNA to Pdk1 (Fig 5C and 5D). While the engraftment in mice transplanted with LT-HSCs was more strongly affected, the relative contribution of donor cells remained higher for MPPs. The reason for different effects by the two shRNAs to Pdk1 on LT-HSCs and MPP, respectively, is not known but could be due to different levels of knockdown and dose-dependent effects. When the contribution between myeloid and lymphoid cells were analyzed after 3 and 6 weeks, there was no effect of Pdk1 shRNA on lymphoid and myeloid cells in MPPs (Fig 5C). In LT-HSCs expressing shRNA to Pdk1 there was a trend towards reduced lymphoid contribution but this was not statistically significant (Fig 5D). Taken together, the in vivo analyses corroborate on the essential role of PDK1 in both long- and short-term HSC populations.
Discussion
In this study, we demonstrate that Pdk1 is a HIF-1α-target gene in LSK cells in vitro, that ex vivo expanded BM colonies of Hif-1αΔ/Δ mice cultured in hypoxia are unable to express Pdk1, and that PDK1 is essential for the integrity of both LT-HSCs and MPPs upon transplantation. Taken together, the results indicate that Pdk1 is a hypoxia-inducible gene mediated by HIF-1α, and that PDK1 is involved in HSC function. This would be in agreement with a previous report that PDK1 expression is higher at the protein level in LSK cells compared with more differentiated cells [32]. In addition, we could demonstrate that LT-HSCs, ST-HSCs and MPPs expressed higher levels of Pdk1 compared to more differentiated c-kit+ cells. While this was also the case for expression of Pdk2 and Pdk3, expression of Pdk4 was below the level of detection in our assay. However, we could not find evidence for any effects of conditional Hif-1α deficiency for the expression of Pdk1, or any of the other Pdk family genes, in different cells within the HSC compartment.
These results stands in contrast to what was reported by Takubo et al [21], in which they showed that Pdk2 and Pdk4 were decreased in LT-HSCs in Hif-1αΔ/Δ mice. Similar to our results however, Takubo et al showed that Pdk1 expression was higher in HSCs and early progenitors compared to later progeny. One plausible explanation to the discrepancies between the two studies could be the use of different mouse strains or the experimental design to induce conditional knockdown, which may lead to distinct effects in the BM. Moreover, the effects of gene ablation at steady state-hematopoiesis could be different than shRNA knockdown in transplantable BM cells. Since compensatory upregulation of HIF-2α in HSCs ablated for HIF-1α has been reported previously [33], this could also differ between the two studies.
Our results that PDK1 is essential for both LT-HSCs and transient MPPs imply that PDK1 has a broad function in multiple progenitor cells. This is supported by the in vitro clonogenic assay with MPPs where Pdk1 silencing partial impaired colony formation. Although our study suggests that Pdk1 is a target for HIF-1α in HSCs, Pdk1 expression was also reduced in colonies with deleted Hif-1α grown in normoxia. This indicates that Pdk1 can be controlled by both hypoxia-dependent and -independent mechanisms, both however requiring HIF-1α activity. Previous studies have demonstrated that SCF and TPO with positive effects on HSCs can activate HIF-1α under normoxic conditions [34, 35]. In addition, HIF-1α contributes to regulation of growth factor-stimulated metabolism in the absence of hypoxia [36]. Since both SCF and TPO were included in our cultures, the results corroborate on an essential role of PDK1 in both long- and short-term HSC populations, but that PDK1 expression is not exclusively dependent on hypoxia.
Concordant it was recently shown that HSCs from ArntΔ/Δ mice deficient in the common β subunit of Hif (Hif-1α) or double Hif-1αΔ/Δ x Hif-2αΔ/Δ knockout mice have very small effects on the expression of Pdk1, Pdk2 and Pdk4 [14]. In addition, a recent report has shown that inducible deletion of Hif-1α had no impact on HSC survival [15]. Thus, although Pdk family members are expressed at high levels in HSCs, and PDK1 appears important for proper HSCs function upon transplantation to recipient mice, the link between HIF regulation on Pdk activity is still an open issue.
Recently, it was demonstrated that HSCs upon transplantation do not seem to seek out specific hypoxic niches as sites for preferential homing in post-chemotherapy or radiation-ablated BM [5]. Since the oxygen tension is elevated in ablated BM [5], it is possible that the effect of silencing of Hif-1α or any of the Pdk genes could differ between HSC transplantation and at steady state hematopoiesis. If the hypoxic status of HSCs and more committed progenitors is related to cell-specific mechanisms rather than different oxygen levels at any defined regions [37], LT-HSCs, ST-HSCs, and MPPs could all be located in hypoxic BM regions and depend on PDK1 for proper function. Given that our study indicates Pdk1 expression at equal levels in LT-HSCs and MPPs, but at higher levels compared to differentiated c-kit- cells, PDK1 appears to be important for both HSCs and multipotent progenitor cells.
Conclusions
Our study demonstrates for the first time that PDK1 is a critical factor for engraftment of HSCs and multipotent progenitors. The results that both long-term and short-term reconstitution was impaired when Pdk1 expression was silenced suggest that PDK1 is essential not only in LT-HSCs but also in multipotent progenitor cells. Therefore, we believe that PDK1 plays a significant role in hematopoiesis at transplantation, but that it also has broad effects in multiple stem and progenitor cells. The exact role of each individual PDK member needs to be further explored to determine if they have distinct, similar and/or overlapping function. Due to conflicting results to the importance of HIF-1α to maintain HSCs, it also remains to clarify if PDK1 function in the BM is dependent on its hypoxic nature and whether Pdk1, and other Pdk genes, are under HIF-1α control.
Supporting information
Acknowledgments
The cell sorting was done at Linköping University Core facility for Flow Cytometry. We thank P. Druid, Z. Kertész, and T. Velasco-Hernandez for expert technical help.
Data availability
All relevant data are within the paper and its Supporting Information files.
Funding Statement
This work was supported by grants from: Swedish Research Council, http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html; Swedish Cancer Society, https://www.cancerfonden.se/om-cancerfonden/about-the-swedish-cancer-society; Swedish Childhood Cancer Foundation, https://www.barncancerfonden.se/in-english/; County Council of Östergötland, http://www.regionostergotland.se/Forskning-och-innovation/Samverkan-kring-forskning/Organisation-och-beslutsvagar/FoU-gruppen/; Faculty of Medicine at Linköping University, https://liu.se/medfak/?l=en; and Ollie and Elof Ericssons Foundation, http://oestiftelse.se/ansokan.html.
References
- 1.Boulais PE, Frenette PS. Making sense of hematopoietic stem cell niches. Blood. 2015;125(17):2621–9. 10.1182/blood-2014-09-570192 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Morrison SJ, Scadden DT. The bone marrow niche for haematopoietic stem cells. Nature. 2014;505(7483):327–34. 10.1038/nature12984 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Morikawa T, Takubo K. Hypoxia regulates the hematopoietic stem cell niche. Pflugers Archiv: European journal of physiology. 2015; [DOI] [PubMed] [Google Scholar]
- 4.Parmar K, Mauch P, Vergilio JA, Sackstein R, Down JD. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci USA. 2007;104(13):5431–6. Epub 2007/03/22. 10.1073/pnas.0701152104 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Spencer JA, Ferraro F, Roussakis E, Klein A, Wu J, Runnels JM, et al. Direct measurement of local oxygen concentration in the bone marrow of live animals. Nature. 2014;508:269–73. Epub 10.1038/nature13034 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Suda T, Takubo K, Semenza GL. Metabolic regulation of hematopoietic stem cells in the hypoxic niche. Cell Stem Cell. 2011;9(4):298–310. Epub 2011/10/11. 10.1016/j.stem.2011.09.010 [DOI] [PubMed] [Google Scholar]
- 7.Ito K, Hirao A, Arai F, Takubo K, Matsuoka S, Miyamoto K, et al. Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nature medicine. 2006;12(4):446–51. 10.1038/nm1388 [DOI] [PubMed] [Google Scholar]
- 8.Simsek T, Kocabas F, Zheng J, Deberardinis RJ, Mahmoud AI, Olson EN, et al. The distinct metabolic profile of hematopoietic stem cells reflects their location in a hypoxic niche. Cell Stem Cell. 2010;7(3):380–90. Epub 2010/09/02. 10.1016/j.stem.2010.07.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Kallio PJ, Pongratz I, Gradin K, McGuire J, Poellinger L. Activation of hypoxia-inducible factor 1alpha: posttranscriptional regulation and conformational change by recruitment of the Arnt transcription factor. Proc Natl Acad Sci USA. 1997;94(11):5667–72. Epub 1997/05/27. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Wang GL, Jiang BH, Rue EA, Semenza GL. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA. 1995;92(12):5510–4. Epub 1995/06/06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Huang LE, Arany Z, Livingston DM, Bunn HF. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem. 1996;271(50):32253–9. Epub 1996/12/13. [DOI] [PubMed] [Google Scholar]
- 12.Nakayama K, Frew IJ, Hagensen M, Skals M, Habelhah H, Bhoumik A, et al. Siah2 regulates stability of prolyl-hydroxylases, controls HIF1alpha abundance, and modulates physiological responses to hypoxia. Cell. 2004;117(7):941–52. Epub 2004/06/24. 10.1016/j.cell.2004.06.001 [DOI] [PubMed] [Google Scholar]
- 13.Takubo K, Goda N, Yamada W, Iriuchishima H, Ikeda E, Kubota Y, et al. Regulation of the HIF-1alpha level is essential for hematopoietic stem cells. Cell Stem Cell. 2010;7(3):391–402. Epub 2010/09/02. 10.1016/j.stem.2010.06.020 [DOI] [PubMed] [Google Scholar]
- 14.Krock BL, Eisinger-Mathason TS, Giannoukos DN, Shay JE, Gohil M, Lee DS, et al. The aryl hydrocarbon receptor nuclear translocator is an essential regulator of murine hematopoietic stem cell viability. Blood. 2015;125(21):3263–72. 10.1182/blood-2014-10-607267 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Vukovic M, Sepulveda C, Subramani C, Guitart AV, Mohr J, Allen L, et al. Adult hematopoietic stem cells lacking Hif-1alpha self-renew normally. Blood. 2016;127(23):2841–6. 10.1182/blood-2015-10-677138 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kim JW, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006;3(3):177–85. Epub 2006/03/07. 10.1016/j.cmet.2006.02.002 [DOI] [PubMed] [Google Scholar]
- 17.Papandreou I, Cairns RA, Fontana L, Lim AL, Denko NC. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 2006;3(3):187–97. Epub 2006/03/07. 10.1016/j.cmet.2006.01.012 [DOI] [PubMed] [Google Scholar]
- 18.Prigione A, Rohwer N, Hoffmann S, Mlody B, Drews K, Bukowiecki R, et al. HIF1alpha Modulates Cell Fate Reprogramming Through Early Glycolytic Shift and Upregulation of PDK1-3 and PKM2. Stem Cells. 2014;32(2):364–76. Epub 2013/10/15. 10.1002/stem.1552 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Gudi R, Bowker-Kinley MM, Kedishvili NY, Zhao Y, Popov KM. Diversity of the pyruvate dehydrogenase kinase gene family in humans. J Biol Chem. 1995;270(48):28989–94. Epub 1995/12/01. [DOI] [PubMed] [Google Scholar]
- 20.Rowles J, Scherer SW, Xi T, Majer M, Nickle DC, Rommens JM, et al. Cloning and characterization of PDK4 on 7q21.3 encoding a fourth pyruvate dehydrogenase kinase isoenzyme in human. J Biol Chem. 1996;271(37):22376–82. Epub 1996/09/13. [DOI] [PubMed] [Google Scholar]
- 21.Takubo K, Nagamatsu G, Kobayashi CI, Nakamura-Ishizu A, Kobayashi H, Ikeda E, et al. Regulation of glycolysis by Pdk functions as a metabolic checkpoint for cell cycle quiescence in hematopoietic stem cells. Cell Stem Cell. 2013;12(1):49–61. Epub 2013/01/08. 10.1016/j.stem.2012.10.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Ryan HE, Poloni M, McNulty W, Elson D, Gassmann M, Arbeit JM, et al. Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res. 2000;60(15):4010–5. Epub 2000/08/17. [PubMed] [Google Scholar]
- 23.Eliasson P, Rehn M, Hammar P, Larsson P, Sirenko O, Flippin LA, et al. Hypoxia mediates low cell-cycle activity and increases the proportion of long-term-reconstituting hematopoietic stem cells during in vitro culture. Exp Hematol. 2010;38(4):301–10 e2. Epub 2010/02/09. 10.1016/j.exphem.2010.01.005 [DOI] [PubMed] [Google Scholar]
- 24.Kubota Y, Takubo K, Suda T. Bone marrow long label-retaining cells reside in the sinusoidal hypoxic niche. Biochem Biophys Res Commun. 2008;366(2):335–9. Epub 2007/12/01. 10.1016/j.bbrc.2007.11.086 [DOI] [PubMed] [Google Scholar]
- 25.Shima H, Takubo K, Iwasaki H, Yoshihara H, Gomei Y, Hosokawa K, et al. Reconstitution activity of hypoxic cultured human cord blood CD34-positive cells in NOG mice. Biochem Biophys Res Commun. 2009;378(3):467–72. Epub 2008/11/27. 10.1016/j.bbrc.2008.11.056 [DOI] [PubMed] [Google Scholar]
- 26.Tang Y, Halvarsson C, Eliasson P, Jonsson JI. Hypoxic and normoxic in vitro cultures maintain similar numbers of long-term reconstituting hematopoietic stem cells from mouse bone marrow. Exp Hematol. 2012;40(11):879–81. 10.1016/j.exphem.2012.07.005 [DOI] [PubMed] [Google Scholar]
- 27.Adolfsson J, Mansson R, Buza-Vidas N, Hultquist A, Liuba K, Jensen CT, et al. Identification of Flt3+ lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell. 2005;121(2):295–306. 10.1016/j.cell.2005.02.013 [DOI] [PubMed] [Google Scholar]
- 28.Christensen JL, Weissman IL. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc Natl Acad Sci USA. 2001;98(25):14541–6. Epub 2001/11/29. 10.1073/pnas.261562798 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Yang L, Bryder D, Adolfsson J, Nygren J, Mansson R, Sigvardsson M, et al. Identification of Lin(-)Sca1(+)kit(+)CD34(+)Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. Blood. 2005;105(7):2717–23. 10.1182/blood-2004-06-2159 [DOI] [PubMed] [Google Scholar]
- 30.Pietras EM, Reynaud D, Kang YA, Carlin D, Calero-Nieto FJ, Leavitt AD, et al. Functionally Distinct Subsets of Lineage-Biased Multipotent Progenitors Control Blood Production in Normal and Regenerative Conditions. Cell Stem Cell. 2015;17(1):35–46. 10.1016/j.stem.2015.05.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Kondo M. Lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors. Immunol Rev. 2010;238(1):37–46. 10.1111/j.1600-065X.2010.00963.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Klimmeck D, Hansson J, Raffel S, Vakhrushev SY, Trumpp A, Krijgsveld J. Proteomic cornerstones of hematopoietic stem cell differentiation: distinct signatures of multipotent progenitors and myeloid committed cells. Molecular & Cellular Proteomics. 2012;11(8):286–302. Epub 2012/03/29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Kocabas F, Zheng J, Thet S, Copeland NG, Jenkins NA, DeBerardinis RJ, et al. Meis1 regulates the metabolic phenotype and oxidant defense of hematopoietic stem cells. Blood. 2012;120(25):4963–72. 10.1182/blood-2012-05-432260 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Pedersen M, Lofstedt T, Sun J, Holmquist-Mengelbier L, Pahlman S, Ronnstrand L. Stem cell factor induces HIF-1alpha at normoxia in hematopoietic cells. Biochem Biophys Res Commun. 2008;377(1):98–103. Epub 2008/10/07. 10.1016/j.bbrc.2008.09.102 [DOI] [PubMed] [Google Scholar]
- 35.Kirito K, Fox N, Komatsu N, Kaushansky K. Thrombopoietin enhances expression of vascular endothelial growth factor (VEGF) in primitive hematopoietic cells through induction of HIF-1alpha. Blood. 2005;105(11):4258–63. 10.1182/blood-2004-07-2712 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Lum JJ, Bui T, Gruber M, Gordan JD, DeBerardinis RJ, Covello KL, et al. The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev. 2007;21(9):1037–49. 10.1101/gad.1529107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Nombela-Arrieta C, Pivarnik G, Winkel B, Canty KJ, Harley B, Mahoney JE, et al. Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment. Nat Cell Biol. 2013;15(5):533–43. Epub 2013/04/30. 10.1038/ncb2730 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All relevant data are within the paper and its Supporting Information files.